Abstract:Abstract Background We investigated the value of three-dimensional amide proton transfer-weighted imaging (3D-APTWI) in the diagnosis of early-stage breast cancer (BC) and its correlation with the immunohistochemical characteristics of malignant lesions. Methods Seventy-eight women underwent APTWI and dynamic contrast-enhanced (DCE)-MRI. Pathological results were categorized as either benign ( n = 43) or malignant ( n = 37) lesions. The parameters of APTWI and DCE-MRI were compared between the benign and malignant groups. The diagnostic value of 3D-APTWI was evaluated using the area under the receiver operating characteristic curve (ROC-AUC) to establish a diagnostic threshold. Pearson’s correlation was used to analyze the correlation between the magnetization transfer asymmetry (MTR asym ) and immunohistochemical characteristics. Results The MTR asym and time-to-peak of malignancies were significantly lower than those of benign lesions (all p < 0.010). The volume transfer constant, rate constant, and wash-in and wash-out rates of malignancies were all significantly greater than those of benign lesions (all p < 0.010). ROC-AUCs of 3D-APTWI, DCE-MRI, and 3D-APTWI+DCE to differential diagnosis between early-stage BC and benign lesions were 0.816, 0.745, and 0.858, respectively. Only the difference between AUC APT+DCE and AUC DCE was significant ( p < 0.010). When a threshold of MTR asym for malignancy for 2.42%, the sensitivity and specificity of 3D-APTWI for BC diagnosis were 86.5% and 67.6%, respectively; MTR asym was modestly positively correlated with pathological grade ( r = 0.476, p = 0.003) and Ki-67 ( r = 0.419, p = 0.020). Conclusions 3D-APTWI may be used as a supplementary method for patients with contraindications of DCE-MRI. MTR asym can imply the proliferation activities of early-stage BC. Relevance statement 3D-APTWI can be an alternative diagnostic method for patients with early-stage BC who are not suitable for contrast injection. Key points • 3D-APTWI reflects the changes in the microenvironment of early-stage breast cancer. • Combined 3D-APTWI is superior to DCE-MRI alone for early-stage breast cancer diagnosis. • 3D-APTWI improves the diagnostic accuracy of early-stage breast cancer. Graphical Abstract

Differentiation of Malignant and Benign Head and Neck Tumors with Amide Proton Transfer-Weighted MR Imaging

Preliminary exploration of amide proton transfer weighted imaging in differentiation between benign and malignant bone tumors

Combining Amide Proton Transfer-Weighted and Arterial Spin Labeling Imaging to Differentiate Solitary Brain Metastases from Glioblastomas

Amide proton transfer-weighted magnetic resonance imaging for the differentiation of parotid gland tumors

Quantitative Analysis and Pathological Basis of Signal Intensity on T2-Weighted MR Images in Benign and Malignant Parotid Tumors.

Amide proton transfer-weighted MRI for renal tumors: Comparison with diffusion-weighted imaging

Feasibility of Amide Proton Transfer-Weighted Imaging at 3T for Renal Masses: A Preliminary Study.

Application of Amide Proton Transfer Imaging in Differentiating Glioma from Treatment Effect

Three‐dimensional turbo‐spin‐echo amide proton transfer‐weighted mri for cervical cancer: A preliminary study

Comparative Study of Amide Proton Transfer‐Weighted Imaging and Intravoxel Incoherent Motion Imaging in Breast Cancer Diagnosis and Evaluation

Amid proton transfer (APT) and magnetization transfer (MT) MRI contrasts provide complimentary assessment of brain tumors similarly to proton magnetic resonance spectroscopy imaging (MRSI)

Synthetic MRI plus FSE-PROPELLER DWI for differentiating malignant from benign head and neck tumors: a preliminary study

Non-invasive Differentiation of Endometrial Adenocarcinoma from Benign Lesions in the Uterus by Utilization of Amide Proton Transfer-Weighted MRI

Amide proton transfer MR imaging of prostate cancer: a preliminary study.

Amide-proton-transfer MRI signal as biomarker of glioma as assessed by image-guided needle biopsy

Amide proton transfer-weighted MRI in predicting pathological types of brain metastases in lung Cancer

Evaluation of Amide Proton Transfer Imaging for Bladder Cancer Histopathologic Features: A Comparative Study with Diffusion- Weighted Imaging

APTw combined with mDixon−Quant imaging to distinguish the differentiation degree of cervical squamous carcinoma

Amide Proton Transfer Weighted MRI in Differential Diagnosis of Ovarian Masses with Cystic Components: A Preliminary Study.

3D amide proton transfer-weighted imaging may be useful for diagnosing early-stage breast cancer: a prospective monocentric study

Using Amide Proton Transfer-Weighted Magnetic Resonance Imaging (MRI) in Peritumor Tissue to Predict Parametrial Infiltration of Cervical Cancer: a Case-Control Study